REDHILL BIOPHARMA LTD. (RDHL) Net income 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.3MFY2024 · since FY2015: -$21.1M → -$8.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$8.3M | -134.6% |
| FY2023 | $23.9M | +133.4% |
| FY2022 | -$71.7M | +26.7% |
| FY2021 | -$97.7M | -28.3% |
| FY2020 | -$76.2M | -80.1% |
| FY2019 | -$42.3M | -9.0% |
| FY2018 | -$38.8M | +14.8% |
| FY2017 | -$45.5M | -55.1% |
| FY2016 | -$29.4M | -39.3% |
| FY2015 | -$21.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice